AT411388T
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
128 members in 14 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 15877499 | United States of America | P | |
| 50395400 | United States of America | A |
Members128
| Document | Office | Kind | |
|---|---|---|---|
| CA2387184A1 | Canada | A1 | |
| WO0127268A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU784845C | Australia | C | |
| AU7938200A | Australia | A | |
| WO0127268A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2002127676A1 | United States of America | A1 | |
| JP2003511071A | Japan | A | |
| EP1303600A2 | European Patent Office (EPO) | A2 | |
| US2003108539A1 | United States of America | A1 | |
| CA2471762A1 | Canada | A1 | |
| WO03057725A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003201733A1 | Australia | A1 | |
| US6610820B1 | United States of America | B1 | |
| US2003175920A1 | United States of America | A1 | |
| US2003220480A1 | United States of America | A1 | |
| CA2488695A1 | Canada | A1 | |
| WO03103698A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003274820A1 | Australia | A1 | |
| US2004082509A1 | United States of America | A1 | |
| WO2004066596A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003214969A1 | Australia | A1 | |
| US6780970B2 | United States of America | B2 | |
| WO03057725A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1487870A2 | European Patent Office (EPO) | A2 | |
| US2005043241A1 | United States of America | A1 | |
| EP1511507A1 | European Patent Office (EPO) | A1 | |
| US2005106695A1 | United States of America | A1 | |
| JP2005525096A | Japan | A | |
| JP2006501165A | Japan | A | |
| AU784845B2 | Australia | B2 | |
| US7120247B1 | United States of America | B1 | |
| EP1776958A2 | European Patent Office (EPO) | A2 | |
| EP1811033A1 | European Patent Office (EPO) | A1 | |
| HK1098961A1 | Hong Kong, China | A1 | |
| EP1511507B1 | European Patent Office (EPO) | B1 | |
| AT372125T | Austria | T | |
| ATE372125T1 | Austria | T1 | |
| HK1100958A1 | Hong Kong, China | A1 | |
| DE60316149D1 | Germany | D1 | |
| EP1776958A3 | European Patent Office (EPO) | A3 | |
| JP2008024710A | Japan | A | |
| EP1895005A1 | European Patent Office (EPO) | A1 | |
| EP1905830A1 | European Patent Office (EPO) | A1 | |
| EP1911458A2 | European Patent Office (EPO) | A2 | |
| EP1914310A2 | European Patent Office (EPO) | A2 | |
| EP1914310A3 | European Patent Office (EPO) | A3 | |
| EP1911458A3 | European Patent Office (EPO) | A3 | |
| HK1111635A1 | Hong Kong, China | A1 | |
| HK1111732A1 | Hong Kong, China | A1 | |
| EP1970070A2 | European Patent Office (EPO) | A2 | |
| AT411388TThis record | Austria | T | |
| ATE411388T1 | Austria | T1 | |
| EP1303600B1 | European Patent Office (EPO) | B1 | |
| AU2003201733B2 | Australia | B2 | |
| DE60040564D1 | Germany | D1 | |
| EP1776958B1 | European Patent Office (EPO) | B1 | |
| PT1303600E | Portugal | E | |
| AU2003274820B2 | Australia | B2 | |
| DK1303600T3 | Denmark | T3 | |
| AT417623T | Austria | T | |
| ATE417623T1 | Austria | T1 | |
| DE60325429D1 | Germany | D1 | |
| PT1776958E | Portugal | E | |
| US2009069234A1 | United States of America | A1 | |
| ES2313906T3 | Spain | T3 | |
| DK1776958T3 | Denmark | T3 | |
| ES2319454T3 | Spain | T3 | |
| EP2060265A2 | European Patent Office (EPO) | A2 | |
| SI1776958T1 | Slovenia | T1 | |
| US7635681B2 | United States of America | B2 | |
| US2010056459A1 | United States of America | A1 | |
| JP2010053136A | Japan | A | |
| JP4460445B2 | Japan | B2 | |
| EP1970070A3 | European Patent Office (EPO) | A3 | |
| EP2060265A3 | European Patent Office (EPO) | A3 | |
| CA2471762C | Canada | C | |
| US2010216716A1 | United States of America | A1 | |
| US7803749B2 | United States of America | B2 | |
| US7943574B2 | United States of America | B2 | |
| JP2011155990A | Japan | A | |
| CA2488695C | Canada | C | |
| EP1811033B1 | European Patent Office (EPO) | B1 | |
| AT541929T | Austria | T | |
| ATE541929T1 | Austria | T1 | |
| PT1811033E | Portugal | E | |
| EP1905830B1 | European Patent Office (EPO) | B1 | |
| AT548455T | Austria | T | |
| ATE548455T1 | Austria | T1 | |
| EP1905830B8 | European Patent Office (EPO) | B8 | |
| DK1811033T3 | Denmark | T3 | |
| US8183339B1 | United States of America | B1 | |
| ES2381206T3 | Spain | T3 | |
| US2012142613A1 | United States of America | A1 | |
| US2012148590A1 | United States of America | A1 | |
| ES2383824T3 | Spain | T3 | |
| DK1905830T3 | Denmark | T3 | |
| US8236924B2 | United States of America | B2 | |
| US8278413B2 | United States of America | B2 | |
| EP2532357A2 | European Patent Office (EPO) | A2 | |
| US2013059798A1 | United States of America | A1 |
Showing 100 of 128
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 969730
Titles2
- German
- ZELL-DURCHLÄSSIGE PEPTIDINHIBITOREN DES JNK- SIGNALTRANSDUKTIONSWEGES
- English
- CELL TRANSMIT PEPTIDINHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATH
Classification
- CPC, 25
- C07K14/4703
- A61K38/00
- A61P3/00
- C07K2319/00
- A61P7/00
- C07K2319/10
- A61P9/00
- A61P9/10
- A61P11/16
- A61P17/00
- A61P17/06
- A61P17/16
- A61P19/02
- A61P25/18
- A61P29/00
- A61P31/18
- A61P35/00
- A61P35/02
- A61P37/00
- A61P37/02
- A61P37/04
- A61P37/08
- A61P39/00
- A61P39/06
- A61P43/00
- IPC, 30
- A61K31 7088
- A61K38 00
- A61K38 17
- A61K39 395
- A61K48 00
- A61P17 16
- A61P25 18
- A61P3 00
- A61P35 00
- A61P37 00
- A61P37 08
- A61P39 00
- A61P39 06
- A61P43 00
- A61P9 00
- A61P9 10
- C07K14 16
- C07K14 47
- C07K16 10
- C07K16 18
- C07K19 00
- C12N1 15
- C12N1 19
- C12N1 21
- C12N15 09
- C12N15 12
- C12N15 62
- C12N5 10
- C12N9 99
- C12P21 02